Patients want pharmaceutical companies to reach out to them through more digital channels, and to offer more value-add services, according to a new survey from Accenture of 2,000 American adults who are taking one or more medications and have a household income of $25,000 or more.
“Providing personalized and value-add services in support of the products they sell is common across almost every other consumer-facing industry from retail to telecomm, hi-tech and travel,” Accenture writes in the report. “Why should pharma be any different? Especially when addressing something as important as someone’s health?”
New York-based Curious, a company that aims to provide people with platform on which they can ask health questions and collaborate with others to find answers, is planning to launch its online platform this summer, according toan article in Fast Company. 23andMe cofounder Linda Avey is one of three founders that started the company.
Health technology is advancing so rapidly that within a decade the small handheld medical reader used by Dr. Leonard McCoy in Star Trek — the tricorder — will look primitive.
We are moving into an era of data-driven, crowdsourced, participatory, genomics-based medicine. Just as our bathroom scales give us instant readings of our weight, wearable devices will monitor our health and warn us when we are about to get sick. Our doctors — or their artificial intelligence replacements — will prescribe medicines or lifestyle changes based on our full medical history, holistic self, and genetic composition.
“The takeaway is that digital health, mobile health, can be used for cardiovascular disease prevention, especially in a high risk group,” lead researcher Dr. R. Jay Widmer told MobiHealthNews. “But the success of an intervention does depend on the use and the amount of use. This is something that can be used to reduce disease burden across the healthcare system at times when paying for value is going to be at a premium.”
Facebook's $2 billion acquisition of Oculus VR is one sign of the growing business thirst for using virtual reality technology to change ways of working and improve customer experiences.
While the acquisition potentially brings Facebook a brand new way to enable people to communicate and share experiences, experts note that it also demonstrates the increased potential in other industries, ranging from medicine right through to retail, for vastly different business.
This week we got a deep look at the rumored new health and fitness tracking application for Apple’s next iPhone, called Healthbook. Supposedly, Healthbook will not only track things like how much exercise and sleep you’re getting, but also your blood pressure, your blood sugar levels, and much more. All that collection will be great, but without a way to not just collate them, but make them meaningful, it runs the risk of becoming data clutter.
Google Glass is facing some challenges in terms of public perception and an ongoing debate about its role in the public forum, but it has some potential in specific realms that could be very exciting, apart from its ability to be a huge consumer success. One such application is in medicine, and startup Augmedix just raised $3.2 million to help show how Glass can be useful to doctors.
Information about Apple’s new Healthbook app for iOS sheds light on what types of quantified self data you may be able to track on an iPhone. Some of that information, however, will have to come from external sensors and devices; perhaps an Apple smart watch?
ThriveOn is an online and mobile service that offers intake, counseling, and exercises for people with mental health issues. The idea is to make mental health care as easy as other online services by helping patients avoid long wait times, in-person interactions, and costly fees.
Despite all the new wearables on the market, there still aren't many apps in these devices' app stores. And without apps, there's not a great reason for mainstream consumers to adopt the devices.
The wearable app ecosystem's immaturity is largely a result of platform fragmentation. The smartphone market is dominated by Android and iOS. Developers can choose to create apps for either one of these platforms knowing that they are reaching a wide swath of the smartphone market.
Not so for the wearables market. It isn't just that there's no dominant platform yet, the devices are also in the hands of far fewer users (compared to smartphone brands), creating an even greater disincentive to create apps for any one wearable device.
While the world has been squabbling about Glassholes, doctors have quietly been testing the potential of Google Glass in medicine. Features that may seem silly to use in a cafe or on the subway have real advantages in the doctor's office. Hand-free control? Remote diagnosis? On-demand medical records? Check check check. Now researchers are testing how Glass could benefit patients with Parkinson's.
Smartphone-based medication adherence tools are rapidly becoming en established niche in digital health, and we’ve seen a range of form factors: medication reminder apps, smart pillboxes, and connected pill bottle caps to name a few. Cypress, Texas-based MedeStat is putting another twist on digital medication adherence with PillBacker, a smartphone case with built in compartments for pills, paired with a medication reminder app.
Most patients taking prescription medicine (72%) also use mobile apps (Android smartphone, iPhone, Android tablet, iPad, or Kindle Fire),
Mobile app adoption rates are high across all medication-taking adult age groups: 93% (age 18-24), 90% (age 25-34), 88% (age 35-44), 80% (age 45-54), 66% (age 55-64), and 50% (age 65+),
App-using patients prefer the privacy-protected single app Mobile Health Library (MHL) system (by a factor of 11 to 1) over email programs often offered by medication manufacturers. This high preference for a privacy-protected single app, customized to a user's needs for medication education and support services, was observed across all adult age groups.
IBM has announced that it would be using Watson, the system that famously wiped the floor with human Jeopardy champions, to tackle a somewhat more significant problem: choosing treatments for cancer. In the process, the company hopes to help usher in the promised era of personalized medicine.
The announcement was made at the headquarters of IBM's partner in this effort, the New York Genome Center; its CEO, Robert Darnell called the program "not purely clinical and not purely research." Rather than seeking to gather new data about the mutations that drive cancer, the effort will attempt to determine if Watson can parse genome data and use it to recommend treatments.
This summer is shaping up to be a very healthy season—if you’re a maker of digital fitness apps. Both Apple and Google are scheduled to hold their big, annual events for developers, with new programming tools for health software taking center stage.
At Apple's Worldwide Developers Conference, the star of the show seems likely to be the rumored Healthbook, a repository for biological signals—“biosignals," for short. And Google seems poised to unveil details of Android Wear, its new platform for wearable devices, at Google I/O.
Google today announced that it plans to officially bring Android to smartwatches through its new project entitled Android Wear. The project will enable developers to bring features such as Google voice search and health tracking apps to wristwatches.
There is a great deal of attention being paid to mobile health applications at the moment, especially in the context of wearable technology. For example, Samsung, Apple and even Google, have recently made clear the focus they will place on this exciting intersection of biology, medicine, healthcare and digital technology.
However, some statistics suggest 90% of health apps are deleted or not used again after 10 days, so getting it wrong can be a terrible waste of investment. From my experience, there are four key principles that tend to define if an application in healthcare will work, and if it is likely to be used:.